(Q50579312)

15 March 2018

review article

1 reference

title

[Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C]. (English)

1 reference

15 March 2018

1 reference

1 reference

Ali Khalil

1

1 reference

15 March 2018

Damien Lucidarme

2

1 reference

15 March 2018

Philippe Desurmont

3

1 reference

15 March 2018

Rima Hamdan-Khalil

4

1 reference

15 March 2018

Bernard Filoche

5

1 reference

15 March 2018

language of work or name

French

0 references

publication date

1 February 2005

1 reference

15 March 2018

Gastroenterologie Clinique et Biologique

published in

1 reference

15 March 2018

volume

29

1 reference

15 March 2018

issue

2

1 reference

15 March 2018

page(s)

193-196

1 reference

15 March 2018

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

Side effects of alpha interferon in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

Colitis associated with alpha interferon?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

1 reference

7 January 2021

Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

Onset of coeliac disease during treatment with interferon for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

Hepatitis B and C virus infection in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

Ulcerative colitis associated with interferon treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2980736-5

7 January 2021

10.1016/S0399-8320(05)80736-5

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018